Switching off an enzyme that plays an important role in sugar metabolism, glycolysis, would normally be expected to cause serious problems for cells. Surprisingly, the opposite is also true: Cells can ...
An illustration shows the structure of an inhibitor bound to the active site of membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase. An inhibitor bound to the active site of ...
KRAS is one of the oncogenes most frequently altered in cancer, mutated in approximately one-third of lung adenocarcinomas.
Drug discovery has long faced a stubborn reality: Most disease-relevant proteins lack the deep, hydrophobic pockets required for inhibition by conventional small-molecule drugs. Beginning in the early ...
In every organism, the regulation of cell populations is a constant process. This balance relies on a continuous interplay ...
A study led by University of Cincinnati Cancer Center researchers sheds new light on how pancreatic cancer cells resist treatment and points to potential new combination therapies to make treatments ...
From the paper: ""Ketone bodies are janitors of damaged proteins, chaperoning away molecular waste so organisms can operate ...
Data showcase advances across oncology pipeline including pan-mutant BRAF, CBL-B and AURKA programsPresentations reinforce potential of degraders ...
Protein claims may dominate packaging, but the next wave of innovation is happening at the molecular level. From bioactive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results